回盛生物：公司一直重视依法合规经营

Core Viewpoint - The company emphasizes its commitment to legal compliance and adherence to regulatory requirements for listed companies [2] Group 1 - The company responded to investor inquiries on November 5, indicating its focus on lawful and compliant operations [2] - The company operates strictly in accordance with the regulatory requirements for listed companies [2]